Registration Decision RD2021-06, Fluazaindolizine and Salibro Nematicide

This decision is consistent with the Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide, whichcontains a detailed evaluation of the information submitted in support of this registration.

Data and Resources

Additional Info

Field Value
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward